FDA Updates for Week of May 13: First Bispecific Antibody for Solid Tumor
FDA Approves Bispecific Antibody for Small Cell Lung Cancer The FDA has granted accelerated approval for Amgen’s Imdelltra (tarlatamab-dlle) to treat adult patients with extensive-stage small cell lung cancer (ES-SCLC). It is indicated for patients with …